Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9422 |
High Similarity |
NPD8053 |
Approved |
0.9422 |
High Similarity |
NPD8054 |
Approved |
0.9017 |
High Similarity |
NPD8251 |
Approved |
0.9017 |
High Similarity |
NPD8252 |
Approved |
0.9017 |
High Similarity |
NPD8099 |
Discontinued |
0.8966 |
High Similarity |
NPD8156 |
Discontinued |
0.8556 |
High Similarity |
NPD8453 |
Clinical (unspecified phase) |
0.8424 |
Intermediate Similarity |
NPD7906 |
Approved |
0.8125 |
Intermediate Similarity |
NPD8095 |
Phase 1 |
0.8108 |
Intermediate Similarity |
NPD7313 |
Approved |
0.8108 |
Intermediate Similarity |
NPD7312 |
Approved |
0.8108 |
Intermediate Similarity |
NPD7311 |
Approved |
0.8108 |
Intermediate Similarity |
NPD7310 |
Approved |
0.8066 |
Intermediate Similarity |
NPD27 |
Approved |
0.8066 |
Intermediate Similarity |
NPD2489 |
Approved |
0.8065 |
Intermediate Similarity |
NPD7309 |
Approved |
0.8056 |
Intermediate Similarity |
NPD3051 |
Approved |
0.8011 |
Intermediate Similarity |
NPD4577 |
Approved |
0.8011 |
Intermediate Similarity |
NPD4578 |
Approved |
0.8011 |
Intermediate Similarity |
NPD2969 |
Approved |
0.8011 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7979 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7965 |
Intermediate Similarity |
NPD2421 |
Approved |
0.7965 |
Intermediate Similarity |
NPD2420 |
Approved |
0.7919 |
Intermediate Similarity |
NPD4584 |
Approved |
0.7877 |
Intermediate Similarity |
NPD6788 |
Approved |
0.7833 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.7833 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.7833 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD7667 |
Clinical (unspecified phase) |
0.7674 |
Intermediate Similarity |
NPD4664 |
Clinical (unspecified phase) |
0.7667 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.7663 |
Intermediate Similarity |
NPD6071 |
Discontinued |
0.7654 |
Intermediate Similarity |
NPD4773 |
Phase 2 |
0.7654 |
Intermediate Similarity |
NPD4772 |
Phase 2 |
0.7611 |
Intermediate Similarity |
NPD7298 |
Approved |
0.7588 |
Intermediate Similarity |
NPD3450 |
Approved |
0.7588 |
Intermediate Similarity |
NPD3452 |
Approved |
0.7588 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7588 |
Intermediate Similarity |
NPD2493 |
Approved |
0.7581 |
Intermediate Similarity |
NPD4481 |
Phase 3 |
0.7577 |
Intermediate Similarity |
NPD2488 |
Approved |
0.7577 |
Intermediate Similarity |
NPD2490 |
Approved |
0.7554 |
Intermediate Similarity |
NPD7201 |
Clinical (unspecified phase) |
0.7542 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7514 |
Intermediate Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.7488 |
Intermediate Similarity |
NPD6997 |
Phase 2 |
0.7487 |
Intermediate Similarity |
NPD2898 |
Approved |
0.7486 |
Intermediate Similarity |
NPD4581 |
Clinical (unspecified phase) |
0.7475 |
Intermediate Similarity |
NPD4583 |
Approved |
0.7475 |
Intermediate Similarity |
NPD4582 |
Approved |
0.7452 |
Intermediate Similarity |
NPD7047 |
Phase 3 |
0.7446 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7432 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7432 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7426 |
Intermediate Similarity |
NPD4002 |
Approved |
0.7426 |
Intermediate Similarity |
NPD4004 |
Approved |
0.7401 |
Intermediate Similarity |
NPD3845 |
Phase 1 |
0.7387 |
Intermediate Similarity |
NPD2975 |
Approved |
0.7387 |
Intermediate Similarity |
NPD2973 |
Approved |
0.7387 |
Intermediate Similarity |
NPD2974 |
Approved |
0.738 |
Intermediate Similarity |
NPD4010 |
Discontinued |
0.736 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.736 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7345 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD7827 |
Phase 1 |
0.7306 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7303 |
Intermediate Similarity |
NPD2422 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7277 |
Intermediate Similarity |
NPD4580 |
Approved |
0.7268 |
Intermediate Similarity |
NPD2971 |
Approved |
0.7268 |
Intermediate Similarity |
NPD2968 |
Approved |
0.7268 |
Intermediate Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.7247 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7238 |
Intermediate Similarity |
NPD6031 |
Approved |
0.7238 |
Intermediate Similarity |
NPD6030 |
Approved |
0.7231 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD8153 |
Approved |
0.7225 |
Intermediate Similarity |
NPD8152 |
Approved |
0.7222 |
Intermediate Similarity |
NPD1424 |
Approved |
0.7213 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7213 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7207 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7196 |
Intermediate Similarity |
NPD7907 |
Approved |
0.7192 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD6042 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD42 |
Phase 2 |
0.7181 |
Intermediate Similarity |
NPD5677 |
Discontinued |
0.7174 |
Intermediate Similarity |
NPD6072 |
Discontinued |
0.7158 |
Intermediate Similarity |
NPD4017 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7802 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD3641 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3640 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD3639 |
Approved |
0.7136 |
Intermediate Similarity |
NPD4040 |
Phase 1 |
0.7088 |
Intermediate Similarity |
NPD6090 |
Discontinued |
0.7074 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7072 |
Intermediate Similarity |
NPD7598 |
Phase 2 |
0.7065 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7053 |
Intermediate Similarity |
NPD6107 |
Approved |
0.7027 |
Intermediate Similarity |
NPD6723 |
Discontinued |
0.7026 |
Intermediate Similarity |
NPD6996 |
Clinical (unspecified phase) |
0.7014 |
Intermediate Similarity |
NPD5676 |
Approved |
0.7011 |
Intermediate Similarity |
NPD4474 |
Approved |
0.7011 |
Intermediate Similarity |
NPD4475 |
Approved |
0.6973 |
Remote Similarity |
NPD6523 |
Clinical (unspecified phase) |
0.6971 |
Remote Similarity |
NPD3109 |
Approved |
0.6971 |
Remote Similarity |
NPD3110 |
Approved |
0.6959 |
Remote Similarity |
NPD7493 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD3057 |
Approved |
0.6957 |
Remote Similarity |
NPD2122 |
Discontinued |
0.6957 |
Remote Similarity |
NPD3448 |
Approved |
0.6957 |
Remote Similarity |
NPD2491 |
Approved |
0.6954 |
Remote Similarity |
NPD5718 |
Phase 2 |
0.6954 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6949 |
Remote Similarity |
NPD2200 |
Suspended |
0.6944 |
Remote Similarity |
NPD5177 |
Phase 3 |
0.694 |
Remote Similarity |
NPD4123 |
Phase 3 |
0.6936 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6936 |
Remote Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD7048 |
Phase 3 |
0.6923 |
Remote Similarity |
NPD6667 |
Approved |
0.6923 |
Remote Similarity |
NPD6666 |
Approved |
0.6915 |
Remote Similarity |
NPD7046 |
Clinical (unspecified phase) |
0.6915 |
Remote Similarity |
NPD5772 |
Approved |
0.6915 |
Remote Similarity |
NPD5773 |
Approved |
0.6911 |
Remote Similarity |
NPD4666 |
Phase 3 |
0.6907 |
Remote Similarity |
NPD5602 |
Clinical (unspecified phase) |
0.6906 |
Remote Similarity |
NPD6748 |
Discontinued |
0.6906 |
Remote Similarity |
NPD7466 |
Approved |
0.6897 |
Remote Similarity |
NPD7262 |
Phase 1 |
0.6897 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6891 |
Remote Similarity |
NPD8051 |
Clinical (unspecified phase) |
0.6889 |
Remote Similarity |
NPD7037 |
Approved |
0.6888 |
Remote Similarity |
NPD7479 |
Phase 2 |
0.6885 |
Remote Similarity |
NPD3124 |
Discontinued |
0.6884 |
Remote Similarity |
NPD6853 |
Approved |
0.6884 |
Remote Similarity |
NPD6851 |
Approved |
0.6882 |
Remote Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6878 |
Remote Similarity |
NPD6284 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD5006 |
Approved |
0.6875 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD2972 |
Approved |
0.6875 |
Remote Similarity |
NPD3533 |
Approved |
0.6875 |
Remote Similarity |
NPD5005 |
Approved |
0.6875 |
Remote Similarity |
NPD1613 |
Approved |
0.6872 |
Remote Similarity |
NPD1632 |
Clinical (unspecified phase) |
0.6869 |
Remote Similarity |
NPD7132 |
Clinical (unspecified phase) |
0.6866 |
Remote Similarity |
NPD4111 |
Phase 1 |
0.6866 |
Remote Similarity |
NPD4665 |
Approved |
0.6859 |
Remote Similarity |
NPD5709 |
Phase 3 |
0.6857 |
Remote Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.6854 |
Remote Similarity |
NPD7718 |
Clinical (unspecified phase) |
0.6853 |
Remote Similarity |
NPD6297 |
Approved |
0.6848 |
Remote Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.6839 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6837 |
Remote Similarity |
NPD5312 |
Approved |
0.6837 |
Remote Similarity |
NPD5313 |
Approved |
0.6837 |
Remote Similarity |
NPD4873 |
Discontinued |
0.6824 |
Remote Similarity |
NPD6503 |
Clinical (unspecified phase) |
0.6822 |
Remote Similarity |
NPD7169 |
Suspended |
0.6818 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.6816 |
Remote Similarity |
NPD1753 |
Discontinued |
0.6812 |
Remote Similarity |
NPD3837 |
Clinical (unspecified phase) |
0.6811 |
Remote Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.6811 |
Remote Similarity |
NPD3647 |
Clinical (unspecified phase) |
0.6806 |
Remote Similarity |
NPD8005 |
Clinical (unspecified phase) |
0.68 |
Remote Similarity |
NPD7922 |
Phase 1 |
0.68 |
Remote Similarity |
NPD5155 |
Approved |
0.68 |
Remote Similarity |
NPD5156 |
Approved |
0.6796 |
Remote Similarity |
NPD7045 |
Clinical (unspecified phase) |
0.6786 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6784 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6782 |
Remote Similarity |
NPD7291 |
Discontinued |
0.6776 |
Remote Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.6776 |
Remote Similarity |
NPD5160 |
Discontinued |
0.6776 |
Remote Similarity |
NPD3692 |
Discontinued |
0.6774 |
Remote Similarity |
NPD5976 |
Discontinued |
0.6772 |
Remote Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.6768 |
Remote Similarity |
NPD6496 |
Clinical (unspecified phase) |
0.6763 |
Remote Similarity |
NPD4420 |
Approved |
0.676 |
Remote Similarity |
NPD6111 |
Discontinued |
0.676 |
Remote Similarity |
NPD6895 |
Approved |
0.676 |
Remote Similarity |
NPD6896 |
Approved |
0.6758 |
Remote Similarity |
NPD3060 |
Approved |
0.6753 |
Remote Similarity |
NPD4166 |
Phase 2 |
0.6743 |
Remote Similarity |
NPD3594 |
Approved |
0.6743 |
Remote Similarity |
NPD2606 |
Approved |
0.6743 |
Remote Similarity |
NPD2605 |
Approved |
0.6743 |
Remote Similarity |
NPD3595 |
Approved |
0.674 |
Remote Similarity |
NPD4726 |
Approved |
0.674 |
Remote Similarity |
NPD4725 |
Approved |
0.674 |
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.674 |
Remote Similarity |
NPD4721 |
Approved |
0.6739 |
Remote Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.6737
|
Remote Similarity |
NPD2978 |
Approved |